FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

(2016) John K. Lee et al.   CANCER CELL

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

(2016) Himisha Beltran et al.   NATURE MEDICINE

Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas

(2015) H. Tsai et al.   CLINICAL CANCER RESEARCH

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

(2015) X. Zhang et al.   CLINICAL CANCER RESEARCH

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

(2015) Shusuke Akamatsu et al.   Cell Reports

Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis

(2014) Hai Tao Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Small cell carcinoma of the prostate

(2014) Rosa Nadal et al.   Nature Reviews Urology

Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers11This work was partially supported by grants from DoD PCRP program (W81XWH-09-1-0455) and KUMC Valk Foundation to Dr Benyi Li, and grants from China Natural Science Foundation to Dr Benyi Li (NSFC #81172427) and Dr Jun Yang (NSFC #81101927). This project was also supported by the “Chutian Scholar” program funded by Hubei Province of China dedicated to China Three Gorges University.

(2013) Ruibao Chen et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration

(2012) Jichao Qin et al.   Cell Stem Cell

Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2

(2012) Aparna Gupta et al.   PROSTATE

PC3 is a cell line characteristic of prostatic small cell carcinoma

(2011) Sheng Tai et al.   PROSTATE

Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

(2011) H. Beltran et al.   Cancer Discovery

Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors

(2010) Jianfei Qi et al.   CANCER CELL

Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model

(2010) X Yu et al.   ONCOGENE

Small Cell Carcinoma of the Prostate

(2009) Wenle Wang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Activation of β-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration

(2008) Xiuping Yu et al.   PROSTATE

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer

(2008) M Hammad Ather et al.   BMC Urology

Dissociation of Epithelial and Neuroendocrine Carcinoma Lineages in the Transgenic Adenocarcinoma of Mouse Prostate Model of Prostate Cancer

(2007) Teresa Chiaverotti et al.   AMERICAN JOURNAL OF PATHOLOGY